Resources from the same session
Revisiting the adjuvant therapy in endometrial cancer: ESMO Guidelines
Presenter: Carien Creutzberg
Session: Endometrial cancer
Resources:
Slides
Webcast
Is immunotherapy changing the face of recurrent/metastatic endometrial cancer?
Presenter: Ana Oaknin
Session: Endometrial cancer
Resources:
Slides
Webcast
Beyond immunotherapy: What is the role of HER2, p53 and other molecular targets in the recurrent/metastatic endometrial cancer treatment landscape?
Presenter: Mansoor Raza Mirza
Session: Endometrial cancer
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Endometrial cancer
Resources:
Webcast